Dlx5 Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-62005r-100uL |
| Product Name | Dlx5 Recombinant Antibody |
| Applications |
WB
IHC-P
IHC-F
IP
IF
ICC/IF
|
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human DLX5 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 1749 |
| Swiss Prot | P56178 |
| Subcellular location | Nucleus |
| Synonyms | Distal less homeo box 5; Dlx 5; Homeo box protein DLX 5. |
| Background | Transcriptional factor involved in bone development. Acts as an immediate early BMP-responsive transcriptional activator essential for osteoblast differentiation. Stimulates ALPL promoter activity in a RUNX2-independent manner during osteoblast differentiation. Stimulates SP7 promoter activity during osteoblast differentiation. |
| Application Dilution | |
| WB | 1:500-2000 |
| IHC-P | 1:50-200 |
| IHC-F | 1:50-200 |
| IP | 1:50-200 |
| IF | |
| ICC/IF | 1:50-100 |
Frequently asked questions
Which applications is Dlx5 Recombinant Antibody (bsm-62005R) validated for, and at what dilution?
bsm-62005R is validated for WB (1:500-2000); IHC-P (1:50-200); IHC-F (1:50-200); IP (1:50-200); IF; ICC/IF (1:50-100). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does Dlx5 Recombinant Antibody (bsm-62005R) react with?
Tested reactivity: Human, Mouse, Rat.
How should bsm-62005R be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
What immunogen was used to raise Dlx5 Recombinant Antibody (bsm-62005R)?
KLH conjugated synthetic peptide derived from human DLX5